Literature DB >> 8964718

Presence of WBC, decreased strength, and delayed soreness in muscle after eccentric exercise.

D L MacIntyre1, W D Reid, D M Lyster, I J Szasz, D C McKenzie.   

Abstract

The purposes of this study were to assess the presence of 99mTc-labeled white blood cells (WBC) in exercised muscle compared with nonexercised muscle over time and to determine the time course of delayed onset muscle soreness (DOMS) and eccentric torque in 10 female subjects. A pretest was followed by 300 eccentric repetitions of the right quadriceps. DOMS and eccentric torque were measured at 2, 4, 20, 24, 48, and 72 h postexercise. Eccentric torque was also tested at 0 h. Radionuclide images of both quadriceps were taken at 2, 4, 20, and 24 h postexercise. The presence of 99mTc-WBC in the exercised muscle was significantly greater (P < 0.001) than in the nonexercised muscle. Eccentric torque declined at 0 and 24 h postexercise. DOMS peaked at 24 h postexercise. The presence of 99mTc-WBC in the exercised muscle in the first 24 h suggests that acute inflammation occurs as a result of exercise-induced muscle injury. The bimodal pattern of eccentric torque supports the hypothesis that more than one mechanism is involved.

Entities:  

Mesh:

Year:  1996        PMID: 8964718     DOI: 10.1152/jappl.1996.80.3.1006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  45 in total

1.  Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Authors:  Richard M Lovering; Patrick G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

2.  Voluntary activation and mechanical performance of human triceps surae muscle after exhaustive stretch-shortening cycle jumping exercise.

Authors:  Sami Kuitunen; J Avela; H Kyröläinen; P V Komi
Journal:  Eur J Appl Physiol       Date:  2003-11-25       Impact factor: 3.078

3.  The effects of massage on delayed onset muscle soreness.

Authors:  J E Hilbert; G A Sforzo; T Swensen
Journal:  Br J Sports Med       Date:  2003-02       Impact factor: 13.800

4.  VGluT2 and NMDAR1 expression in cells in the inflammatory infiltrates in experimentally induced myositis: evidence of local glutamate signaling suggests autocrine/paracrine effects in an overuse injury model.

Authors:  Christoph Spang; Alexander Scott; Patrik Danielson; Ronny Lorentzon; Sture Forsgren
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

5.  Changes in the soleus muscle architecture after exhausting stretch-shortening cycle exercise in humans.

Authors:  M Ishikawa; E Dousset; J Avela; H Kyröläinen; J Kallio; V Linnamo; S Kuitunen; C Nicol; P V Komi
Journal:  Eur J Appl Physiol       Date:  2006-04-21       Impact factor: 3.078

6.  The effects of high-intensity exercise on skeletal muscle neutrophil myeloperoxidase in untrained and trained rats.

Authors:  Vladimir I Morozov; Pavel V Tsyplenkov; Natalia D Golberg; Michael I Kalinski
Journal:  Eur J Appl Physiol       Date:  2006-06-22       Impact factor: 3.078

7.  Effect of whirlpool therapy on the signs and symptoms of delayed-onset muscle soreness.

Authors:  L A Kuligowski; S M Lephart; F P Giannantonio; R O Blanc
Journal:  J Athl Train       Date:  1998-07       Impact factor: 2.860

Review 8.  Altering the length-tension relationship with eccentric exercise : implications for performance and injury.

Authors:  Matt Brughelli; John Cronin
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

9.  The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair.

Authors:  Timothy A Butterfield; Thomas M Best; Mark A Merrick
Journal:  J Athl Train       Date:  2006 Oct-Dec       Impact factor: 2.860

10.  Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome.

Authors:  J G Cannon; J B Angel; L W Abad; J O'Grady; N Lundgren; L Fagioli; A L Komaroff
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.